Solutions by Modality
Cosmetics
We conduct preclinical studies for vaccine candidates using various platforms, including protein-based, mRNA, DNA, and viral vector vaccines (e.g., AAV, adenovirus). Our expertise ensures robust data generation and tailored solutions for IND submissions.
Key Services
- Efficacy evaluation: Tumor cell-killing ability and tissue regeneration effects
- Safety studies: Evaluation of tumorigenesis and immune rejection
- Distribution studies: qPCR-based evaluation of in vivo distribution
Highlights
- IND packaging expertise for CAR-T therapies (first in Korea)
- Extensive experience in CAR-NK and enhanced MSC-based therapeutic research
- Tailored experimental designs and compliance with global regulatory standards